IGC Pharma, Inc. Logo

IGC Pharma, Inc.

Clinical-stage biotech firm developing AI-driven treatments for Alzheimer's disease.

IGC | US

Overview

Corporate Details

ISIN(s):
US45408X3089
LEI:
Country:
United States of America
Address:
10224 FALLS ROAD, 20854 POTOMAC

Description

IGC Pharma, Inc. is a clinical-stage biotechnology company focused on developing treatments for Alzheimer's disease. The company leverages artificial intelligence (AI) in its development process. Its lead candidate, IGC-AD1, is being evaluated in a Phase 2 clinical trial for treating agitation in patients with dementia due to Alzheimer's. The company's pipeline also includes TGR-63, a pre-clinical small molecule designed to inhibit amyloid plaque aggregation. Supporting its therapeutic development is MINT-AD, an AI-powered platform for the early detection of Alzheimer's and to improve the understanding of disease progression.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-02 17:02
FORM 8-K
English ZIP 86.1 KB
2025-12-15 17:02
FORM 8-K
English ZIP 725.5 KB
2025-12-08 01:15 English ZIP 5.1 KB
2025-12-03 17:05
FORM S-3/A
English ZIP 64.3 KB
2025-11-14 19:19
FORM S-3
English ZIP 100.7 KB
2025-11-14 18:27
FORM S-8
English ZIP 65.9 KB
2025-11-14 17:11
FORM 10-Q
English ZIP 1.2 MB
2025-11-14 11:03
FORM 8-K
English ZIP 110.8 KB
2025-10-22 10:29 English ZIP 7.0 KB
2025-10-21 10:50 English ZIP 6.9 KB
2025-10-21 10:47 English ZIP 5.7 KB
2025-10-21 10:44 English ZIP 4.7 KB
2025-10-20 22:10 English ZIP 7.4 KB
2025-10-10 21:49
FORM 8-K
English ZIP 145.3 KB
2025-10-01 18:40
FORM 8-K
English ZIP 104.2 KB

Automate Your Workflow. Get a real-time feed of all IGC Pharma, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IGC Pharma, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IGC Pharma, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.